Has Rodrigo Mendirichaga Magana, MD received payments from drug or device companies?

Yes. Drug and device makers reported $20,761 in general payments to Rodrigo Mendirichaga Magana, MD across 60 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rodrigo Mendirichaga Magana, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rodrigo Mendirichaga Magana, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rodrigo Mendirichaga Magana, MD

Interventional Cardiology · Dover, NHNPI 1225443963

Payments from drug & device makers

What this record shows

This record is dominated by grants: $17,000 of the $20,761 with a category attached, or 81.9%. 16 manufacturers reported payments, led by Medtronic at 38.0% of the total. Reporting peaked in 2020 at $12,036 and has fallen 98.5% since, to $183 in 2025. Among interventional cardiology clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$20,761in general payments, 2019–2025

Across 60 payments — averaging $346.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$8K
Abbott$6K
Boston Scientific$5K
Abiomed$315
Terumo Medical Corporation$235
Shockwave Medical, Inc$186
plus $822 from 10 others

What the payments were for

Grants$17,00082%
Food & beverage$3,76118%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	8	$7,899
Abbott	16	$5,827
Boston Scientific	6	$5,478
Abiomed	6	$315
Terumo Medical Corporation	3	$235
Shockwave Medical, Inc	1	$186
Cardiovascular Systems Inc.	4	$168
Siemens Medical Solutions USA, Inc.	1	$163
Biotronik Inc.	3	$160
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	6	$131
E.r. Squibb & Sons, L.L.C.	1	$70
Inari Medical, Inc.	1	$38
W. L. Gore & Associates, Inc.	1	$27
Acist Medical Systems, Inc.	1	$24
Chiesi USA, Inc.	1	$21
Cordis US CORP.	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GENERAL - STENTS$5,000
AMPLATZER PICCOLO$432
Avalus$264
GlideWire$191
Heartrail$191
METACROSS OTW$191
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$186
GUIDEZILLA$166
Artis icono floor$163
Perclose ProStyle$150
GENERAL VASCULAR ACCESS$150
CARDIOMEMS$148
AMPLATZER$131
MitraClip System$126
Impella$125

How this compares

$20,761 in reported general payments places this provider in the 90th percentile of 26 interventional cardiology providers in New Hampshire.

See all interventional cardiology providers in New Hampshire →

Medicare billing

Part B allowed, 2024

$205,434

Medicare patients

1,927

Services billed

4,122

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	107	$132,941
EntrestoSacubitril/Valsartan	42	$48,084
JardianceEmpagliflozin	29	$38,467
WegovySemaglutide	13	$22,558
BrilintaTicagrelor	19	$16,893
Rosuvastatin Calcium	221	$4,596
Ezetimibe	82	$3,949
Metoprolol Succinate	252	$2,824
Colchicine	15	$2,631
Warfarin Sodium	219	$2,471
Atorvastatin Calcium	184	$1,717
Losartan Potassium	105	$1,124
Valsartan	24	$960
Lisinopril	132	$757
Spironolactone	134	$751

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Dover

Nitish SharmaDover$23K
Faisal ShamshadDover$2K
Shahab MoossaviConcord$36K
Hannah ChaudryLebanon$20K
Eric RothsteinLebanon$20K
James DevriesLebanon$19K
Xiaoyu Yang-GiulianoManchester$18K
Lazaro DiazExeter$15K
Aaron KaplanLebanon$13K
Augustin DelagoConcord$7K

See the full list for New Hampshire →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →